Drug Shortage Report for LEVITRA

Last updated on 2018-11-14 History
Report ID 55646
Drug Identification Number 02250489
Brand name LEVITRA
Common or Proper name Vardenafil tablets
Company Name BAYER INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) VARDENAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4's
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-31
Actual start date
Estimated end date 2018-11-19
Actual end date 2018-11-06
Shortage status Resolved
Updated date 2018-11-14
Company comments Product is available to market.
Health Canada comments
Tier 3 Status No
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2018-11-14 French Compare
v13 2018-11-14 English Compare
v12 2018-11-14 French Compare
v11 2018-11-14 English Compare
v10 2018-11-14 English Compare
v9 2018-10-26 French Compare
v8 2018-10-26 English Compare
v7 2018-10-12 French Compare
v6 2018-10-12 English Compare
v5 2018-08-29 French Compare
v4 2018-08-29 English Compare
v3 2018-08-01 English Compare
v2 2018-07-13 French Compare
v1 2018-07-13 English Compare

Showing 1 to 14 of 14